Get our Free Drug Patent Expiration Updates

Serving hundreds of leading biopharmaceutical companies globally:

US Army
QuintilesIMS
Merck
Citi
Colorcon
Moodys

Generated: March 18, 2019

DrugPatentWatch Database Preview

Drugs in Development Information for PF-03715455

« Back to Dashboard

US Patents for PF-03715455

Drugname Patent Number Patent Title Patent Assignee Estimated Expiration
PF-03715455 ➤ Try a Free Trial Triazolopyridinylsulfanyl derivatives as p38 MAP kinase inhibitors Pfizer Inc. (New York, NY) ➤ Try a Free Trial
PF-03715455 ➤ Try a Free Trial Triazolopyridinylsulfanyl derivatives as P38 map kinase inhibitors Pfizer Inc. (New York, NY) ➤ Try a Free Trial
PF-03715455 ➤ Try a Free Trial Polymorphic form of a [1,2,4]triazole[4,3-A] pyridine derivative inflammatory diseases Pfizer Limited (Sandwich, Kent, GB) ➤ Try a Free Trial
PF-03715455 ➤ Try a Free Trial Certain (2S)-N-[(1S)-1-cyano-2-phenylethyl]-1,4-oxazepane-2-carboxamides as dipeptidyl peptidase 1 inhibitors AstraZeneca AB (Sodertalje, SE) ➤ Try a Free Trial
PF-03715455 ➤ Try a Free Trial Certain (25)-N-[(1S)-1-cyano-2-phenylethyl]-1,4-oxazepane-2-carboxamides as dipeptidyl peptidase 1 inhibitors ASTRAZENECA AB (Sodertalje, SE) ➤ Try a Free Trial
PF-03715455 ➤ Try a Free Trial Chemical compounds AstraZeneca AB (Sodertalje, SE) ➤ Try a Free Trial
Drugname Patent Number Patent Title Patent Assignee Estimated Expiration

This preview shows a limited data set.
Subscribe to access the full database, or try a Free Trial

International Patents for PF-03715455

Drugname Country Document Number Estimated Expiration Related US Patent
PF-03715455 African Regional IP Organization (ARIPO) 2326 2024-08-12 ➤ Try a Free Trial
PF-03715455 Argentina 050692 2024-08-12 ➤ Try a Free Trial
PF-03715455 Austria 412652 2024-08-12 ➤ Try a Free Trial
PF-03715455 Australia 2005273612 2024-08-12 ➤ Try a Free Trial
PF-03715455 Brazil PI0514255 2024-08-12 ➤ Try a Free Trial
PF-03715455 Canada 2576297 2024-08-12 ➤ Try a Free Trial
PF-03715455 China 101006087 2024-08-12 ➤ Try a Free Trial
Drugname Country Document Number Estimated Expiration Related US Patent

This preview shows a limited data set.
Subscribe to access the full database, or try a Free Trial

Make Better Decisions: Try a trial or see plans & pricing

Serving hundreds of leading biopharmaceutical companies globally:

McKinsey
Healthtrust
Teva
AstraZeneca
UBS
Baxter

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.